Reps. Mullin, O'Halleran Co-Lead Bill to Combat Counterfeit Pharmaceuticals
May 05, 2022
May 05, 2022
WASHINGTON, May 5 -- Rep. Markwayne Mullin, R-Oklahoma, issued the following news release:
Congressman Markwayne Mullin (OK-02) joined Rep. Tom O'Halleran (AZ-01) yesterday in introducing the "Modern Authentication of Pharmaceuticals" (MAP) Act to combat counterfeit pharmaceuticals. This bipartisan legislation will require on-dose identifiers on controlled substances to ensure the authenticity of essential medicines and enhance the security of the U.S. supply chain. T . . .
Congressman Markwayne Mullin (OK-02) joined Rep. Tom O'Halleran (AZ-01) yesterday in introducing the "Modern Authentication of Pharmaceuticals" (MAP) Act to combat counterfeit pharmaceuticals. This bipartisan legislation will require on-dose identifiers on controlled substances to ensure the authenticity of essential medicines and enhance the security of the U.S. supply chain. T . . .